Skip to main content
. 2018 Jun 17;33(1):1064–1073. doi: 10.1080/14756366.2018.1482285

Figure 1.

Figure 1.

Chemical structures of the compounds used in the study. (A) The nitroimidazole DTP338 (compound 9 in the original study)18 inhibits human CA IX showed inhibition constant Ki 8.3 nM in vitro18. (B) The nitroimidazole DTP348 (compound 7 in original study) inhibitions human of CA IX in vitro at the concentration of 20.4 nM18.